Formosa Laboratories Inc (4746):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Formosa Laboratories Inc (4746) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7946
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Formosa Laboratories Inc (Formosa Laboratories) is a producer of active pharmaceutical ingredients and UV-filters. The company’s active pharmaceutical ingredients include cholesterol and phosphate binders, anticancers, CNS agents, immunomodulators, MRI enhancing agents, anti-inflammatory and analgesic agents, steroids, respiratory agents, and other products. It also provides UV filters such as avobenzone, phenylbenzimidazole sulfonic acid used in sunscreens and cosmetics. Formosa Laboratories offers contract research and custom synthesis services such as route optimization, process development, analytical support, purity assessment, and commercial production services, among others. The company offers its products and services across Taiwan. Formosa Laboratories is headquartered in New Taipei City, Taiwan.

Formosa Laboratories Inc (4746) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Formosa Labs to Form Joint Venture with YungShin Global and Sichuan Neijiang Huixin Pharma 10
Activus Pharma Enters Into Co-Development Agreement With CEOLIA Pharma 11
Equity Offering 12
Formosa Labs Completes Public Offering Of Common Stock For US$1.67 Million 12
Formosa Labs Completes Rights Offering Of Common Stock For US$12.5 Million 13
Debt Offering 14
Formosa Labs to Raise up to USD16.5 Million in Public Offering of Bonds Due 2017 14
Formosa Labs Announces Public Offeiring Of Notes Due 2015 For US$16.8 Million 15
Acquisition 16
Formosa Labs Acquires Activus Pharma from Sosei Group 16
Formosa Laboratories Inc – Key Competitors 17
Formosa Laboratories Inc – Key Employees 18
Formosa Laboratories Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Formosa Laboratories Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Formosa Labs to Form Joint Venture with YungShin Global and Sichuan Neijiang Huixin Pharma 10
Activus Pharma Enters Into Co-Development Agreement With CEOLIA Pharma 11
Formosa Labs Completes Public Offering Of Common Stock For US$1.67 Million 12
Formosa Labs Completes Rights Offering Of Common Stock For US$12.5 Million 13
Formosa Labs to Raise up to USD16.5 Million in Public Offering of Bonds Due 2017 14
Formosa Labs Announces Public Offeiring Of Notes Due 2015 For US$16.8 Million 15
Formosa Labs Acquires Activus Pharma from Sosei Group 16
Formosa Laboratories Inc, Key Competitors 17
Formosa Laboratories Inc, Key Employees 18
Formosa Laboratories Inc, Subsidiaries 19

List of Figures
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Formosa Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Formosa Laboratories Inc (4746):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invion Ltd (IVX):企業の財務・戦略的SWOT分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta adrenergic biased ligand …
  • DNAtrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Centre for Drug Design and Discovery-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, …
  • CEZ, AS (CEZ)-エネルギー分野:企業M&A・提携分析
    Summary CEZ, a.s. (CEZ) is an integrated energy conglomerate that extracts and sells coal; generates and distributes electricity and heat; and trades in electricity, natural gas, and other commodities. It generates electricity from nuclear, coal, gas, hydro, solar, wind, and biogas sources. The comp …
  • Global Petroleum Ltd (GBP):企業の財務・戦略的SWOT分析
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. It operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan de Nova …
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務情報
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Piramal Enterprises Ltd (PEL)-医療機器分野:企業M&A・提携分析
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • CSX Corporation, Inc.:企業の戦略・SWOT・財務情報
    CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ann Inc:企業の戦略的SWOT分析
    Ann Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • SGL Carbon SE:企業の戦略・SWOT・財務分析
    SGL Carbon SE - Strategy, SWOT and Corporate Finance Report Summary SGL Carbon SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Waagner-Biro Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • UCO Bank:企業の戦略・SWOT・財務情報
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Pinnacle Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia International Corp is a drug development company that develops and markets photodynamic therapy products. The company offers products such as OPTIGUIDE PI, ETHYOL PI, PHOTOFRIN PI, and DIOMED products, among others. Its O …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • GR. Sarantis S.A.:企業の戦略・SWOT・財務情報
    GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report Summary GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Green’s General Foods Pty Ltd:企業の戦略・SWOT・財務分析
    Green’s General Foods Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Green’s General Foods Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • eTheRNA Immunotherapies NV:製薬・医療:M&Aディール及び事業提携情報
    Summary ETheRNA Immunotherapies NV (eTheRNA) is a developer of novel immunotherapies for the treatment of cancers and infectious diseases. The company’s pipeline products include mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious disease …
  • TearScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary TearScience Inc (TearScience) is a medical device company that carries out identifying, diagnosing, and treating meibomian gland dysfunction (MGD). The company conducts early detection and treatment of prevalent, chronic, and progressive MGD. It offers LipiFlow thermal pulsation system, a si …
  • Immunogen, Inc.:企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆